Anti-ErbB2 [ICR52]
Invented at The Institute of Cancer Research
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 153390 |
| Applications | IHC |
| Antigen/Gene or Protein Targets | Erb-B2 |
| Synonyms | ERBB2; Tyrosine kinase type cell surface receptor HER2 |
| Reactivity | Human |
| Relevance | Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. |
| Host | Rat |
| Immunogen | Paper not available |
| Subclass | IgG2b |
| Molecular Weight (kDa) | 77 |
| Research Area | Cancer, Cell Type or Organelle Marker, Cell Signaling & Signal Transduction |
References: 2 entries
Styles et al. 1990. Int J Cancer. 45(2):320-4. PMID: 1689275.
Rat monoclonal antibodies to the external domain of the product of the C-erbB-2 proto-oncogene.
Europe PMC ID: 1689275
Add a reference
References: 2 entries
Styles et al. 1990. Int J Cancer. 45(2):320-4. PMID: 1689275.
Rat monoclonal antibodies to the external domain of the product of the C-erbB-2 proto-oncogene.
Add a reference
